相关实验视频

Updated: Jan 7, 2026

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

关于神经炎症驱动性发症新兴免疫点的叙述性审查:从补充途径到免疫检查点

Meet Popatbhai Kachhadia¹, Rochelle Boguslavskiy¹, Olivia Mattner¹

¹Neurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.

|December 29, 2025

概括

神经炎症,包括补充级联,细胞因子信号传递和检查点蛋白,在发育中起着关键作用. 针对这些途径为提供了超出症状抑制的新的治疗策略.

科学领域:

神经免疫学和病研究研究
发生的分子机制.

背景情况:

发症传统上与兴奋毒性和过度兴奋性有关.
新出现的证据凸显了神经炎症在活动中的重要作用.
需要针对疾病生物学而不是仅仅针对症状的疗法.

研究的目的:

审查三个关键的神经炎症途径在发作的作用:补充级联,细胞因子信号传递和PD-1/PD-L1检查点信号传递.
综合实验性,转化性和临床数据关于的免疫失调.
评估当前和研究中的治疗方法和的生物标志物.

主要方法:

科学文献的综述,重点关注补充级联 (C1q,C3/C3aR,C5aR1),细胞因子信号传递 (IL-1β,IL-6) 和PD-1/PD-L1信号传递.
对中炎症途径因果关系的证据分析,包括自身免疫性脑和实验模型.
针对这些途径和新兴生物标志物 (CSF IL-1β,GFAP,TSPO-PET) 的治疗剂的评估.

主要成果:

神经炎症,特别是通过补充介导的突触修剪,质激活和检查点功能障碍,有助于神经元损伤和慢性发作.
证据支持炎症途径在发育过程中起到贡献作用,在某些情况下起因作用.
免疫疗法在自身免疫性中表现有前途;对炎症途径的实验性操纵减少了型活动.

结论:

神经炎症是发作的关键因素,在许多获得性中充当疾病放大剂.
向补充剂,IL-1β和PD-1/PD-L1通路提供了可行的治疗策略.
像CSF IL-1β和GFAP这样的生物标志物,以及组合疗法,显示出潜力,但需要进一步验证.

关键词:

生物标志物生物标志物互补系统是互补的系统.发病的发生是发病的产生.免疫检查点的检查点.神经炎症是一种神经炎症.

更多相关视频

Lipidomics and Transcriptomics in Neurological Diseases

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

相关概念视频

Epilepsy and Seizures: Overview

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...